Robin Weaver

1.6k citations
6 papers · 1.2k indexed · 1 hit paper · h-index 6

Impact in

Papers in

Robin Weaver

6 papers receiving 1.1k citations

Hit Papers

Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment 2000 · 523 citations
5232000202620082017100200300400500

Peers

Robin Weaver
Comparison fields: 5 of 74
  • Pathology and Forensic Medicine 800
  • Genetics 460
  • Oncology 535
  • Radiology, Nuclear Medicine and Imaging 417
  • Immunology 267
Replace Jocelyn Maragulia with:
Jocelyn Maragulia United States
Wolfram Jung Germany
Juan Pablo Alderuccio United States
Sanne H. Tonino Netherlands
Santiago Mercadal Spain
A H Goldstone United Kingdom
Manali Kamdar United States
Dirk Huebner United States
Lawrence D. Durack United States
Matteo Dell’Olio Italy
Robin Weaver relative to Jocelyn Maragulia United States Jocelyn Maragulia's profile →
Citations per field
00.5×3.7×
Jocelyn Maragulia · 1×
Citations per year

Countries citing papers authored by Robin Weaver

Since Specialization
Citations

This map shows the geographic impact of Robin Weaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Weaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Weaver more than expected).

Fields of papers citing papers by Robin Weaver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Weaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Weaver. The network helps show where Robin Weaver may publish in the future.

Co-authors

The 21 scholars most cited alongside Robin Weaver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robin Weaver Line = papers co-authored together Robin Weaver links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1
Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment
Hit paper breakdown →
2000523
2 2004265
3 1999225
4 2001103
5 200623
6
Reducing Behavior Problems in the Elementary School Classroom. IES Practice Guide. NCEE 2008-012.
200819

About Robin Weaver

Robin Weaver is a scholar working on Genetics, Pathology and Forensic Medicine, Oncology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases, having authored 6 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Viral-associated cancers and disorders (2 papers), CAR-T cell therapy research (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (800 citations), Genetics (460 citations), Oncology (535 citations), Radiology, Nuclear Medicine and Imaging (417 citations) and Immunology (267 citations). Robin Weaver has collaborated with scholars based in United States. Frequent co-authors include Antonio J Grillo-López, Myron S. Czuczman, Christine A. White, Ronald Levy, Brian K. Link, Thomas A. Davis, Baha Alkuzweny, Peter McLaughlin, J. Rosenberg and David G. Maloney. Their work appears in journals such as Journal of Clinical Oncology, Annual Review of Medicine and Leukemia & lymphoma.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026